This inventor holds 5 USPTO granted patents and 3 published patent applications, plus 2 CIPO patents and 6 EPO patents. Top assignee: University of Pittsburgh. Active years: 2014-2020.
Location History:
- Centennial, CO (US) (2014)
- Denver, CO (US) (2017 - 2020)
Company Filing History:
Years Active: 2014-2020
Title: Brendan M Giles: Innovator in Influenza Research
Introduction
Brendan M Giles is a prominent inventor based in Denver, CO (US). He has made significant contributions to the field of influenza research, particularly in the development of optimized antigens for H5N1 influenza. With a total of 5 patents, his work has the potential to impact public health significantly.
Latest Patents
One of his latest patents focuses on "Computationally optimized broadly reactive antigens for human and avian H5N1 influenza." This patent describes the generation of optimized H5N1 influenza HA polypeptides designed to elicit a broadly reactive immune response to various H5N1 influenza virus isolates. The optimized HA polypeptides were developed through a series of HA protein alignments and the generation of consensus sequences based on human and avian H5N1 isolates. The patent also includes optimized H5N1 HA polypeptides, compositions, fusion proteins, and virus-like particles (VLPs) comprising these HA polypeptides. Additionally, it provides codon-optimized nucleic acid sequences encoding the HA polypeptides and methods for eliciting an immune response against the influenza virus in a subject.
Career Highlights
Brendan M Giles is affiliated with the University of Pittsburgh, where he continues to advance his research in the field of influenza. His innovative work has garnered attention and respect within the scientific community.
Collaborations
He has collaborated with notable colleagues such as Ted M Ross and Corey J Crevar, contributing to the advancement of research in influenza and related fields.
Conclusion
Brendan M Giles is a key figure in the development of innovative solutions for combating influenza, particularly through his work on optimized antigens. His contributions are vital for enhancing our understanding and response to influenza viruses.